We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,859

House Panel Votes to Tighten Medicaid Income Standards
  • Reed Smith LLP
  • USA
  • February 13 2017

The House Energy and Commerce Subcommittee on Health has approved two bills that would modify Medicaid eligibility rules to consider additional


With Trump’s HHS Secretary in Place, Congress Turns to CMS Nominee
  • Reed Smith LLP
  • USA
  • February 13 2017

The Senate voted early on February 10, 2017 to confirm Thomas Price to be


CMS Provides Sneak Preview of Future DMEPOS Competitive Bidding Plans Before Retracting Announcement
  • Reed Smith LLP
  • USA
  • February 13 2017

One week after unveiling the next round of Medicare durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) competitive bidding, the


Regulatory Freeze Notwithstanding, Trump Administration Increases Health Fraud CMPs
  • Reed Smith LLP
  • USA
  • February 3 2017

The Department of Health and Human Services (HHS) is once again applying an inflation increase to maximum civil monetary penalty (CMP) amounts for


DOJOIG Update on FY 2016 Health Care Fraud and Abuse Control (HCFAC) Program Recoveries
  • Reed Smith LLP
  • USA
  • January 31 2017

Federal health fraud recoveries for FY 2016 totaled $3.3 billion, according to the latest HCFAC program annual report. The HCFAC program is credited


Congressional Budget Resolution Provides Framework for ACA Repeal Legislation, Hearings Focusing on ACA Issues
  • Reed Smith LLP
  • USA
  • January 31 2017

The House and Senate have approved a budget resolution (S.Con.Res. 3) providing instructions to Congressional committees on the federal spending


OIG Reports on Impact of “High-Priced Drugs” on Medicare Part D Catastrophic Coverage Spending
  • Reed Smith LLP
  • USA
  • January 30 2017

At the request of Congress and others, the Office of Inspector General (OIG) conducted a review of “high-priced drugs” (defined by OIG as exceeding


CMS Proposes Stringent New Medicare Standards for Providers and Suppliers of Prosthetics and Custom-Fabricated Orthotics
  • Reed Smith LLP
  • USA
  • January 30 2017

CMS has issued a proposed rule that would set forth qualifications that providers and suppliers must meet in order to furnish, fabricate, or bill for


Congressional Hearings to Focus on Medicaid Reform
  • Reed Smith LLP
  • USA
  • January 30 2017

The House Energy & Commerce Committee has scheduled two hearings this week on Medicaid policy: a January 31 hearing on “Medicaid Oversight: Existing


OIG Report Cites Continuing Vulnerabilities Under Medicare’s 2-Midnight Policy
  • Reed Smith LLP
  • USA
  • January 30 2017

The Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) has issued a report, “Vulnerabilities Remain Under